Magnesium sulfate: The first-line tocolytic

Obstetrics and Gynecology Clinics of North America

Volumn 32, Issue 3, 2005, Pages 485-500

  Lewis, David F ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; FUROSEMIDE; GLUCONATE CALCIUM; GLUCONATE MAGNESIUM; GLUCONIC ACID; GLYCERYL TRINITRATE; INDOMETACIN; ISOXSUPRINE; KETOROLAC; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; ROFECOXIB; TERBUTALINE; UNCLASSIFIED DRUG; UTERUS SPASMOLYTIC AGENT;

APGAR SCORE; BONE DEMINERALIZATION; CLINICAL TRIAL; CONSTIPATION; DIPLOPIA; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DETOXIFICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FETUS BREATHING; FETUS DISEASE; FETUS HEART RATE; FETUS MOVEMENT; FETUS OUTCOME; FEVER; HEADACHE; HOT FLUSH; HUMAN; HYPERMAGNESEMIA; HYPOCALCEMIA; HYPOTENSION; LETHARGY; LONG TERM CARE; LOW DRUG DOSE; LUNG EDEMA; MATERNAL DISEASE; MUSCLE HYPOTONIA; NAUSEA; NEUROPROTECTION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TOCOLYSIS; TREATMENT OUTCOME; UTERUS BLOOD FLOW; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS; TREATMENT OUTCOME;

EID: 23944516964     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2005.03.002     Document Type: Review

References (76)

1. National Center for Health Statistics, Perinatal Overview Available at: http://www.marchofdimes.com/peristats Accessed May 16, 2005
2. J.A. Martin, B.E. Hamilton, and S.J. Ventura Births: final data for 2000 Natl Vital Stat Rep 50 2002 1 101
3. R. Romero, M. Mazor, and H. Munoz The preterm labor syndrome Ann N Y Acad Sci 734 1994 414 429
4. R.L. Goldenberg The management of preterm labor Obstet Gynecol 100 2002 1020 1037
5. C.M. Steer, and R.H. Petrie A comparison of magnesium sulfate and alcohol for the prevention of premature labor Am J Obstet Gynecol 129 1977 1 4
6. J.P. Elliott Magnesium sulfate as a tocolytic agent Am J Obstet Gynecol 147 1983 277 284
7. M.C. Gordon, and J.D. Iams Magnesium sulfate Clin Obstet Gynecol 38 1995 706 712
8. M.F.M. James Magnesium in obstetric anesthesia Inter J Obstet Anes 7 1998 115
9. S. Ohki, M. Ikura, and M. Zhang Identification of magnesium binding sites and the role of magnesium on target recognition by calmodulin Biochemistry 36 1997 4309 4316
10. S.N. Caritis, M.J. Darby, and L. Chan Pharmacologic treatment of preterm labor Clin Obstet Gynecol 31 1988 635 651
11. J.P. Elliott Magnesium sulfate as a tocolytic agent Contemp Ob Gyn 147 1985 277 284
12. D.I. Hollander, D.A. Nagey, and M.J. Pupkin Magnesium sulfate and ritodrine hydrochloride: a randomized comparison Am J Obstet Gynecol 156 1987 631
13. T.O. Idama, and S.W. Lindow Magnesium sulphate: a review of clinical pharmacology applied to obstetrics Br J Obstet Gynaecol 105 1998 260 268
14. D.P. Cruikshank, R.M. Pitkin, and E. Donnelly Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion Obstet Gynecol 58 1981 430 434
15. S. Rodts-Palenik, and J.C. Morrison Tocolysis: an update for the practitioner Obstet Gynecol Surv 57 2002 S9 S34
16. C. Madden, J. Owen, and J.C. Hauth Magnesium tocolysis: serum levels versus success Am J Obstet Gynecol 162 1990 1177 1180
17. M.T. Parsons, C.A. Owens, and W.N. Spellacy Thermic effects of tocolytic agents: decreased temperature with magnesium sulfate Obstet Gynecol 69 1977 88 90
18. J.F. Rodis, A.M. Vintzileos, and W.A. Campbell Maternal hypothermia: an unusual complication of magnesium sulfate therapy Am J Obstet Gynecol 156 1987 435 436
19. A.L. Levav, L. Chan, and R.J. Wapner Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report Am J Perinatol 15 1998 43 46
20. Y. Matsuda, Y. Nagayoshi, and N. Kirihara Rhabdomyolysis during prolonged intravenous tocolytic therapy J Perinat Med 30 2002 514 516
21. H. Sameshima, T. Higo, and Y. Kodama Magnesium tocolysis as the cause of urinary calculus during pregnancy J Matern Fetal Neonatal Med 6 1997 296 297
22. A.C. Chau, H.A. Gabert, and J.M. Miller A prospective comparison of terbutaline and magnesium for tocolysis Obstet Gynecol 80 1992 847
23. J. Anthony, R.G. Johanson, and L. Duley Role of magnesium sulfate in seizure prevention in patients with eclampsia and preeclampsia Drug Saf 15 1996 188
24. P.S. Ramsey, and D.J. Rouse Magnesium sulfate as a tocolytic agent Semin Perinatol 25 2001 236 247
25. G.D.V. Hankins, T.L. Hammond, and E.R. Yeomans Amniotic cavity accumulation of magnesium with prolonged magnesium sulfate tocolysis J Reprod Med 36 1991 446 449
26. R.H. Petrie Tocolysis using magnesium sulfate Semin Perinatol 5 1981 266 273
27. A.M. Peaceman, B.A. Meyer, and J.A. Thorp The effect of magnesium sulfate tocolysis on the fetal biophysical profile Am J Obstet Gynecol 161 1989 771 774
28. J.W. Wright, L.E. Ridgway, and B.D. Wright Effect of MgSO4 on heart rate monitoring in the preterm fetus J Reprod Med 41 1996 605 608
29. S.E. Gray, J.F. Rodis, and L. Lettieri Effect of intravenous magnesium sulfate on the biophysical profile of the healthy preterm fetus Am J Obstet Gynecol 170 1994 1131 1135
30. W.L. Holcomb Jr, G.D. Shackelford, and R.H. Petrie Magnesium tocolysis and neonatal bone abnormalities: a controlled study Obstet Gynecol 78 1991 611 614
31. M.D. Santi, G.W. Henry, and G.L. Douglas Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization J Pediatr Orthop 14 1994 249 253
32. C.I. Lamm, K.I. Norton, and R.J.C. Murphy Congenital rickets associated with magnesium sulfate infusion for tocolysis J Pediatr 113 1988 1078 1082
33. K.B. Nelson, and J.K. Grether Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95 1995 263 269
34. J.C. Hauth, R.L. Goldenberg, and K.G. Nelson Reduction of cerebral palsy with maternal MgSO4 treatment in newborns weighing 500-1000g [abstract] Am J Obstet Gynecol 172 1 pt 2 1995 419
35. D.E. Schendel, C.J. Berg, and M. Yeargin-Allsopp Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years JAMA 276 1996 1805 1810
36. K.C. Kuban, A. Leviton, and M. Pagano Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies J Child Neurol 7 1992 70 76
37. R.B. FineSmith, K. Rocke, and P.B. Yellin Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants Am J Perinatol 14 1997 303 307
38. J.K. Grether, J. Hoogstrate, and S. Selvin Magnesium sulfate tocolysis and risk of neonatal death Am J Obstet Gynecol 178 1998 1 6
39. C.A. Crowther, J.E. Hiller, and L.W. Doyle Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial JAMA 290 2003 2669 2676
40. R. Mittendorf, P. Pryde, and B. Khoshnood If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? Obstet Gynecol 92 1998 308 311
41. R. Scudiero, B. Khoshnood, and P.G. Pryde Perinatal death and tocolytic magnesium sulfate Obstet Gynecol 96 2000 178 182
42. D.F. Kimberlin, J.C. Hauth, and R.L. Goldenberg The effect of maternal magnesium sulfate treatment on neonatal morbidity in ≤1000-gram infants Am J Perinatol 15 1998 635 641
43. K.R. Spisso, G.M. Harbert, and S. Thiagarajah The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery Am J Obstet Gynecol 142 1982 840 845
44. M.M. Taslimi, B.M. Sibai, and E. Amon A national survey on preterm labor Am J Obstet Gynecol 160 1989 1352 1360
45. D.B. Cotton, H.T. Strassner, and L.M. Hill Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor: a randomized study J Reprod Med 29 1984 92 97
46. S.M. Cox, M.L. Sherman, and K.J. Leveno Randomized investigation of magnesium sulfate for prevention of preterm birth Am J Obstet Gynecol 163 1990 767 772
47. C.A. Crowther, J.E. Hiller, and L.W. Doyle Magnesium sulphate for preventing preterm birth in threatened preterm labour. The Cochrane Database of Systematic Reviews 2002 [Issue 4. Art. No.: CD001060. DOI:10.1002/14651858. CD001060]
48. H. Zuckerman, U. Reiss, and I. Ruberstein The inhibition of human premature labor by indomethacin Obstet Gynecol 44 1974 787 792
49. W.J. Morales, and H. Madhav Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study Am J Obstet Gynecol 169 1993 97 102
50. S.J. Schorr, M.H. Ascarelli, and O.A. Rust A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor South Med J 91 1998 1028 1032
51. J. McWhorter, S.J. Carlan, and T.D. O'Leary Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial Obstet Gynecol 103 2004 923 930
52. J.L. Glock, and W.J. Morales Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study Am J Obstet Gynecol 169 1993 960 964
53. J.E. Larmon, B.S. Ross, and W.L. May Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor Am J Obstet Gynecol 181 1999 1432 1437
54. Y.Y. El-Sayed, E.T. Riley, and R.H. Holbrook Jr Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor Obstet Gynecol 93 1999 79 83
55. J.M. Miller Jr, M.W.D. Keane, and E.O. Horger III A comparison of magnesium sulfate and terbutaline for the arrest of premature labor: a preliminary report J Reprod Med 27 1982 348 351
56. A.C. Chau, H.A. Gabert, and J.M. Miller Jr A prospective comparison of terbutaline and magnesium for tocolysis Obstet Gynecol 80 1992 847 851
57. I.A. Wilkins, L. Lynch, and K.E. Mehalek Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents Am J Obstet Gynecol 159 1988 685 689
58. M.H. Beall, B.W. Edgar, and R.H. Paul A comparison of ritodrine, terbutaline, and magnesium for the suppression of preterm labor Am J Obstet Gynecol 153 1985 854 859
59. C.G. Hatjis Ritodrine/magnesium for the treatment of premature labor Am J Obstet Gynecol 150 1984 108
60. C.G. Hatjis, M. Swain, and L.H. Nelson Efficacy of combined administration of magnesium sulfate and ritodrine in the treatment of premature labor Obstet Gynecol 69 1987 317 322
61. P.L. Ogburn Jr, C.A. Hansen, and P.P. Williams Magnesium sulfate and β-mimetic dual-agent tocolysis in preterm labor after single-agent failure J Reprod Med 30 1985 583 587
62. F.H. Coleman Safety and efficacy of combined ritodrine and magnesium sulfate for preterm labor: a method for reduction of complications Am J Perinatol 7 1990 366 369
63. T.S. Kosasa, R. Busse, and N. Wahl Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients Obstet Gynecol 84 1994 369 373
64. D.F. Lewis, A. Grimshaw, and G.G. Brooks A comparison of magnesium sulfate and indomethacin to magnesium sulfate only for tocolysis in preterm labor with advanced cervical dilation South Med J 88 1995 737 740
65. D.A. Terrone, B.K. Rinehart, and E.S. Kimmel A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis Am J Obstet Gynecol 182 6 2000 1477 1482
66. D.F. Lewis, J.W. Gallaspy, and M.T. Fontenot Successful tocolysis: does cervical change affect time to delivery? Am J Perinatol 14 1997 593 596
67. R.W. Martin, D.K. Gaddy, and J.N. Martin Tocolysis with oral magnesium Am J Obstet Gynecol 156 1987 433 434
68. R.W. Martin, K.G. Perry Jr, and L.W. Hess Oral magnesium and the prevention of preterm labor in a high-risk group of patients Am J Obstet Gynecol 166 1992 144 147
69. T.J. Garite, K.A. Keegan, and R.K. Freeman A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation Am J Obstet Gynecol 157 1987 388
70. T. Fontenot, and D.F. Lewis Tocolytic therapy with preterm premature rupture of membranes Clin Perinatol 28 2001 787 796
71. S.J. Fortunato, S.I. Welt, and M. Eggleston Prolongation of the latency period in preterm premature rupture of the membranes using prophylactic antibiotics and tocolysis J Perinatol 10 1990 252
72. Y. Matsuda, T. Ikenoue, and H. Hokanishi Premature rupture of the membranes-aggressive versus conservative approach: effect of tocolytic and antibiotic therapy Gynecol Obstet Invest 36 1993 102
73. D. Dudley, D. Gagnon, and M. Varner Long-term tocolysis with intravenous magnesium sulfate Obstet Gynecol 73 1989 373 378
74. I.A. Wilkins, J.D. Goldberg, and R.N. Phillips Long-term use of magnesium sulfate as a tocolytic agent Obstet Gynecol 67 1986 38S 40S
75. P.G. Pryde, R.E. Besinger, and J.G. Gianopoulos Adverse and beneficial effects of tocolytic therapy Semin Perinatol 25 2001 316 340
76. D.F. Lewis, S. Bergstedt, and M.S. Edwards Successful magnesium sulfate tocolysis: is "weaning" the drug necessary? Am J Obstet Gynecol 177 1997 742 745